Sentences with phrase «gynecologic cancer»

Long - term survival from gynecologic cancer: psychosocial outcomes, supportive care needs and positive outcomes

Depression, correlates of depression and receipt of depression care among low - income women with breast or gynecologic cancer

She beat the disease and is now working with the Gynecologic Cancer Foundation to educate women about human papillomavirus (HPV)-- a group of viruses that cause the vast majority of cervical cancer cases — and the importance of regular Pap tests to screen for cervical cancer.

Every year, 10,000 U.S. women are diagnosed with cervical cancer, and 3,600 die from the disease, according to Debbie Saslow, PhD, director of breast and gynecologic cancer at the American Cancer Society in Atlanta.

The Gynecologic Cancer Program provides complete and compassionate care for women with gynecologic cancers including ovarian, uterine, cervical, vulvar, peritoneal, and fallopian tube cancers, as well as gestational trophoblastic disease.

Our gynecologic cancer specialists combine training and expertise in gynecology, surgery and oncology.

Minimally invasive and robotic surgery is now used for treatment of a majority of women with gynecologic cancer.

At UT Southwestern Medical Center, our gynecologic cancer experts have unmatched expertise in treating patients with ovarian cancer.

My primary research focus has been in the use of individualized approach in the management of gynecologic cancer, extremity soft tissue sarcoma through molecular markers and precision radiotherapy.

The results suggest that assessing baseline QoL in women with PRR - ROC might help identify which patients are unlikely to benefit from palliative chemotherapy, said lead study author Felicia Roncolato, MBChB, FRACP, of St. George Hospital in Sydney, Australia, on behalf of the Gynecologic Cancer Intergroup Symptom Benefit Group.

Endometrial cancer is the most common type of gynecologic cancer in developed countries.

Gynecologic cancer typically originates from the female reproductive organs, and include endometrial and ovarian cancer, among others.

Cervical cancer is the third most common gynecologic cancer in the United States, and takes the life of one of every three women diagnosed with it.

For women with ovarian cancer, a particularly deadly form of gynecologic cancer, even improvements in treatment outcomes have been elusive.

The drug, birinapant, sensitizes the CA125 - negative cells to the chemotherapy by restoring apoptosis, or programmed cell death, said Dr. Sanaz Memarzadeh, a senior author of the study and a UCLA gynecologic cancer surgeon.

Ovarian cancer accounts for 5 percent of cancer deaths among women, and causes more deaths than any other gynecologic cancer.

«Nearly 10 percent of women live too far from access to gynecologic cancer care.»

Shalowitz and colleagues suggest future studies should focus on defining areas with poor clinical outcomes attributed to geographic factors, and creating a comprehensive national, geographically - linked database on the utilization of gynecologic cancer care and clinical outcomes.

«This is the first national study to identify specific regions of the United States where residents may be at an increased risk for poor clinical outcomes — including misdiagnoses and late detection — as a result of limited access to specialized gynecologic cancer care,» says David Shalowitz, MD, a fellow in the division of Gynecologic Oncology at the Perelman School of Medicine at the University of Pennsylvania, and lead author on the study.

ACP found that the diagnostic accuracy of the pelvic examination for detecting gynecologic cancer or infections is low.

Cervical cancer is the easiest gynecologic cancer to prevent with regular screening test and follow - up.

GYN Cancer Support Group - For patients who are diagnosed with a gynecologic cancer.

An oral cancer drug improves outcomes while minimizing side effects in women with gynecologic cancers who carry a BRCA mutation and whose disease is not responding to other therapies, suggests preliminary research.

«Targeted Cancer Therapy May Treat Resistant Gynecologic Cancers.»

More than one - third of counties in the Unites States are located more than 50 miles from the nearest gynecologic oncologist, making access to specialty care for ovarian and other gynecologic cancers difficult for nearly 15 million women.

«Based on our estimates, it's likely that more than 7,000 women with gynecologic cancers per year experience distance - related barriers to accessing appropriate care from a specialist.

The four - year study involved 461 patients at 24 medical oncology clinics at Princess Margaret Cancer Centre, University Health Network (UHN) with advanced lung, gastrointestinal, genitourinary, breast and gynecologic cancers.

«Unfortunately, due to the lack of screening mechanisms for many gynecologic cancers, they are often diagnosed in an advanced stage, thus leading to poor treatment response with standard therapies in many cases.

As part of an ongoing clinical trial at Rutgers Cancer Institute exploring rare and poor prognosis cancers, investigators sought to identify genomic alterations in 69 patients with gynecologic cancers that were not responding to standard care.

«Poor responding gynecologic cancers get boost from genomic profiling.»

Research from Rutgers Cancer Institute of New Jersey examining gynecologic cancers that poorly respond to therapy shows genomic profiling can help identify alternate and targeted treatments.

For most women who have these gynecologic cancers, surgery is an important part of the initial treatment and increases the possibility of long - term success.

Brian M. Slomovitz, M.D., co-leader of the Gynecologic Cancers Site Disease Group at Sylvester Comprehensive Cancer Center, received the 2018 Presidential Abstract Award from the Society for Gynecologic Oncology on March 24 during the group's Annual Meeting on Women's Cancer in New Orleans.

In my laboratory at NYU Langone, I focus on precision medicine, rare tumors, and early detection and prevention of gynecologic cancers.

Our clinical trials for gynecologic cancers offer patients access to cutting - edge therapies that may not be available anywhere else.

To learn more about current immunotherapy treatment options for women with gynecologic cancers, and how close we are to making these treatments available to more patients, watch Dr. Odunsi's webinar from June 4, 2013.

The five main types of gynecologic cancers include: uterine, cervical, vaginal, vulvar, and ovarian.

Her professional and research interests include familial gynecologic cancers; cancer susceptibility in rare genetic syndromes; and psychosocial counseling in cancer - prone families.

The registry tracks the medical history of patients with specific gynecologic cancers who may have been exposed to diethylstilbestrol (DES) or other synthetic hormones while still in their mother's womb.

Anxiety Disorders Arthritis Breast Cancer Cancer Risk Clinic Delayed Puberty Depression Digestive Diseases Eating Disorders Endometriosis Family Planning Gynecologic Conditions Gynecologic Cancers Headaches Heart Disease Incompetent Cervix Incontinence Infertility Lupus Menopause Menstrual Abnormalities Minimally Invasive Gynecologic Surgery Mixed Connective Tissue Disease Multiple Sclerosis Osteoporosis Pelvic and Vulvar Pain Pelvic Floor Defects Personalized Health & Prevention Plastic Surgery Polycystic Ovary Syndrome (PCOS) Pregnancy Scleroderma Sexual Health for Female Cancer Patients and Survivors Sexually Transmitted Diseases Skin Problems Thyroid Problems Urinary Incontinence Uterine Fibroids Varicose Veins Weight Loss Surgery Weight Management

Rodriguez - Rodriguez L, Hirshfield KM, Rojas V, DiPaola RS, Gibbon D, Hellmann M, Isani S, Leiser A, Riedlinger GM, Wagreich A, Ali SM, Elvin JA, Miller VA, Ganesan S. Use of comprehensive genomic profiling to direct point - of - care management of patients with gynecologic cancers.

Viswanathan, considered the preeminent expert in gynecologic radiation therapies, developed MRI - guided brachytherapy for cervical cancer and other gynecologic cancers.

The evolution of cancer treatment continues, particularly in the area of gynecologic cancers.

Our specialists are experienced in detecting and treating gynecologic cancers with the latest medical and surgical treatments.

Here, Kebria, gives us a preview of his panel and shares information about advances in combating gynecologic cancers:

We are in an exciting era of discoveries and advances in cancer treatment, specifically with regard to gynecologic cancers.

Colon, pancreatic, and prostate cancer can also be genetically linked to breast and some gynecologic cancers.

About Youtuber The Society of Gynecologic Oncology (SGO) is the premier medical specialty society for health care professionals trained in the comprehensive management of gynecologic cancers.

Their mission is to promote the highest quality of comprehensive clinical care through education and research in the prevention and treatment of gynecologic cancers.

Not exact matches

Estradiol contributes to most gynecologic problems, including endometriosis and fibroids and even female cancers.